Chongqing Zhifei Biological Products Co., Ltd. (SHE: 300122)

Market Cap	67.55B
Revenue (ttm)	36.43B
Net Income (ttm)	3.69B
Shares Out	2.39B
EPS (ttm)	1.54
PE Ratio	18.33
Forward PE	15.33
Dividend	0.80 (2.83%)
Ex-Dividend Date	Aug 8, 2024

Volume	29,522,901
Open	30.68
Previous Close	29.77
Day's Range	28.19 - 30.68
52-Week Range	20.38 - 70.27
Beta	0.92
Analysts	n/a
Price Target	n/a
Earnings Date	Oct 28, 2024

About Chongqing Zhifei Biological Products

Chongqing Zhifei Biological Products Co., Ltd. engages in the research, development, manufacture, marketing, distribution, import, and export of vaccines and biological products in China. It also provides cold storage services. The company was founded in 2002 and is based in Chongqing, China.

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2002
• Employees: 6,545
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 300122

Financial Performance

In 2023, Chongqing Zhifei Biological Products's revenue was 52.92 billion, an increase of 38.30% compared to the previous year's 38.26 billion. Earnings were 8.07 billion, an increase of 7.04%.